Portfolio Diet for Dyslipidemia: A Hong Kong Pilot Study
Feasibility Study of a Health Education Programme to Improve Portfolio Diet Adherence for Hong Kong Adults With Dyslipidemia
Background:
Dyslipidemia (raised blood cholesterol) is a widespread public health concern in Hong Kong. While medications like statins are commonly used, many individuals hesitate to take them, making effective dietary strategies essential for reducing cardiovascular disease risk. The Portfolio Diet is a proven plant-based dietary pattern that can significantly lower cholesterol levels, but its feasibility has not yet been thoroughly explored or culturally adapted for a non-Western population like Hong Kong.
Purpose:
This feasibility study aims to evaluate whether a culturally tailored Portfolio Diet health education programme is practical, acceptable, and effective for Hong Kong adults with dyslipidemia. The findings will help researchers understand the practical challenges and motivators participants face when trying to change their diet, which will guide the design of a future larger-scale trial.
Methods:
A total of 12 Chinese adults aged 18 to 65 with borderline or high total cholesterol will participate in a 4-week health education programme. The programme begins with a group session explaining the core dietary principles, followed by 3 weekly individual dietary consultations with a research dietitian. The diet plan and sample 7-day menus are culturally adapted to include food items commonly consumed in Chinese culture.
Participants' diet adherence will be assessed using 3-day dietary records at the beginning and end of the study. Additionally, researchers will track feasibility data such as recruitment and retention rates, session attendance, and the completeness of the dietary records. Following the 4-week programme, participants will join focus group interviews to share their personal feedback, experiences, and suggestions for improving the programme for long-term use.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Background and Rationale:
Dyslipidemia is a major public health challenge in Hong Kong, affecting over half of the adult population. While standard management relies on lifestyle advice and pharmacotherapy (e.g., statins), patient hesitancy toward medication remains a significant barrier. The Portfolio Diet-a dietary pattern combining four cholesterol-lowering components (viscous fibers, plant sterols, plant proteins, and nuts)-has demonstrated clinical efficacy in reducing serum low-density lipoprotein-cholesterol (LDL-C) by a mean of 28.6% in Western cohorts. However, its feasibility, acceptability, and efficacy signal have not been explored in non-Western populations whose local dietary habits differ significantly. This feasibility study is a necessary prerequisite to adapt the dietary components into Chinese culture and inform the design of a future full-scale randomized controlled trial (RCT).
Objectives:
- To evaluate the feasibility and process metrics (recruitment, retention, and session attendance rates) of a culturally adapted Portfolio Diet health education programme.
- To assess the acceptability and participant burden (completion and compliance rates of 3-day dietary records).
- To explore the preliminary efficacy signal of the programme in improving Portfolio Diet adherence among Hong Kong adults with dyslipidemia.
- To identify facilitators and barriers to dietary change through qualitative feedback to enhance the future intervention plan.
Study Design and Interventions:
This is an interventional feasibility study utilizing a single-group, pre-post test design combined with a qualitative component. Twelve eligible Chinese adults with dyslipidemia will undergo a 4-week health education programme:
- Week 1 (Group Session): Introduction to the principles of the Portfolio Diet, its cholesterol-lowering mechanisms, and its relationship with cardiometabolic health.
- Weeks 2-4 (Individual Consultations): Three weekly sessions of personalized dietary consultations conducted by a research dietitian. Participants will receive a culturally tailored 7-day menu adjusted to commonly consumed food groups in Chinese culture, targeting five dietary pillars: nuts/seeds (45 g/day), plant protein (50 g/day), viscous fiber (20 g/day), plant sterols (2 g/day), and monounsaturated fatty acid-rich plant fats (45 g/day).
Qualitative Component:
Post-intervention, all 12 participants will be divided into two focus groups (6 participants per group) for a 1-hour semi-structured interview conducted by a trained research assistant. The interviews will be audio-recorded and will systematically explore four domains: programme acceptability, dietary changes and practicality, perceived benefits, and suggestions for long-term implementation in Hong Kong.
Data Collection and Dietary Analysis:
Quantitative clinical and socio-demographic data will be collected at baseline and at week 4 (post-intervention). Dietary adherence will be assessed using 3-day dietary records (2 weekdays and 1 weekend day) completed at both time points. Nutrient and individual component intakes will be rigorously analyzed using Food Processor Nutrition Analysis and Fitness software (Version 8.0, ESHA Research), utilizing localized food composition tables from China and Hong Kong to ensure accuracy.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Ka-hei Kenneth Lo, PhD
- Número de telefone: +852 3400 8778
- E-mail: kenneth.kh.lo@polyu.edu.hk
Locais de estudo
-
-
-
Hong Kong, China
- Department of Food Science and Nutrition, The Hong Kong Polytechnic University
-
Contato:
- Ka-hei Kenneth Lo, PhD
- Número de telefone: +852 3400 8778
- E-mail: kenneth.kh.lo@polyu.edu.hk
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Aged 18-65 years.
- Of Chinese ethnicity.
- Diagnosed with borderline or high total cholesterol (TC ≥ 5.2 mmol/L).
- Overweight or obese, defined as a Body Mass Index (BMI) ≥ 23 kg/m2.
- Currently residing in Hong Kong with no travel plans for the following 12 weeks.
- Able and willing to maintain a regular lifestyle and eating habits throughout the study period.
- Capable of providing voluntary written informed consent.
Exclusion Criteria:
- Known history of alcohol, cigarette, or drug abuse within the past 3 months.
- Known liver and/or renal dysfunction.
- Known history of severe medical conditions (e.g., cardiovascular disease, diabetes, inflammatory bowel disease, cancer, or psychiatric illness).
- Participation in any other interventional clinical trials within the past 3 months.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Portfolio Diet Education Group
A single group of 12 Hong Kong Chinese adults with dyslipidemia who receive a culturally adapted 4-week Portfolio Diet health education programme, followed by qualitative focus group interviews. |
The programme consists of 4 weekly sessions. Week 1 is a group-based session introducing the principles of the Portfolio Diet and its clinical relationship with cardiometabolic health. Weeks 2 to 4 consist of 3 individual dietary consultations conducted by a research dietitian. The dietary components (nuts/seeds, plant protein, viscous fiber, plant sterols, and plant-based fats) are culturally adapted to commonly consumed food groups in Chinese culture. Participants receive a localized 7-day menu to help modify their diet. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Programme Retention Rate
Prazo: At the end of the 4-week intervention
|
The percentage of enrolled participants who successfully complete the entire 4-week health education programme. This metric is used to evaluate the feasibility of the study protocol and participant retention. |
At the end of the 4-week intervention
|
|
Change in Portfolio Diet Adherence Score
Prazo: Baseline and Post-intervention (Week 4)
|
Assessed by 3-day dietary records (covering 2 weekdays and 1 weekend day) to evaluate the change in participant adherence to the Portfolio Diet pillars. Nutrient and dietary component intakes will be analyzed using Food Processor Nutrition Analysis and Fitness software (Version 8.0) with localized food composition tables. |
Baseline and Post-intervention (Week 4)
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Participant Acceptability and Perceived Barriers via Focus Groups
Prazo: Post-intervention (Week 4)
|
Evaluated through post-intervention qualitative focus group interviews (6 participants per group). A semi-structured interview guide will be used to explore four core domains: acceptability of the programme format/duration, dietary changes and practical challenges, perceived health benefits, and suggestions for long-term implementation. |
Post-intervention (Week 4)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Doenças Metabólicas
- Distúrbios do metabolismo lipídico
- Comportamento
- Doenças Nutricionais e Metabólicas
- Adesão e Cumprimento do Tratamento
- Comportamento de saúde
- Conformidade do paciente
- Aceitação dos Cuidados de Saúde pelo Paciente
- Intervenções de adesão
- Adesão à Medicação
- Hipercolesterolemia
- Dislipidemias
- Hiperlipidemias
- Educação saudável
Outros números de identificação do estudo
Outros números de identificação do estudo
- HSEARS20260714006
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
As this is a small-scale pilot feasibility study (N=12) focused on evaluating protocol processes and cultural acceptability, individual participant data will not be made publicly available to protect participant privacy.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .